Home Newsfeeds Matinas BioPharma Hldgs Q2 EPS $(0.03), Inline

Matinas BioPharma Hldgs Q2 EPS $(0.03), Inline

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year.

byBenzinga Newsdesk

August 11, 2022

1 minute read

NeuroStar Achieves Milestone Regulatory Clearance In South Korea

By Happy Mohamed

July 17, 8:48 AM

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced

EWY

Earnings

Honest Co: Q3 Earnings Insights

By Benzinga Insights

November 8, 5:40 PM

Honest Co (NASDAQ:HNST) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:15 PM. Here’s what…

HNST

WEC Energy Group Q4 EPS $0.80 Beats $0.74 Estimate, Sales $2.56B Beat $1.92B Estimate

By Benzinga Newsdesk

February 2, 8:04 AM

WEC Energy Group (NYSE:WEC) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.74 by 8.11 percent. This is a 12.68 percent increase over earnings of $0.71 per share from the

WEC

Earnings

Earnings Preview For Two Harbors Investment

By Benzinga Insights

August 2, 1:05 PM

Two Harbors Investment (NYSE:TWO) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that Two Harbors Investment will report an earnings per share (EPS) of $0.18.

TWO

Matinas BioPharma Hldgs Q2 EPS $(0.03), Inline

Related Posts

NeuroStar Achieves Milestone Regulatory Clearance In South Korea

Honest Co: Q3 Earnings Insights

WEC Energy Group Q4 EPS $0.80 Beats $0.74 Estimate, Sales $2.56B Beat $1.92B Estimate

Earnings Preview For Two Harbors Investment